How rheumatoid arthritis affects survival in older adults with cancer
Impact of rheumatoid arthritis on survival in older adults with cancer
This study is looking at how rheumatoid arthritis affects the survival of older adults who also have cancer, with the goal of finding better ways to treat these patients by understanding how their arthritis and other health factors impact their cancer outcomes.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10906992 on NIH RePORTER |
What this research studies
This research investigates the impact of rheumatoid arthritis (RA) on the survival rates of older adults who also have cancer. It aims to analyze contemporary cohorts of older patients with RA and various types of cancer, focusing on how RA and associated factors like frailty and body composition influence cancer outcomes. The study will utilize data from recent therapies and clinical outcomes to provide evidence-based guidance for managing these patients. By understanding these relationships, the research seeks to improve treatment strategies for older adults facing both conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with both rheumatoid arthritis and cancer.
Not a fit: Patients without rheumatoid arthritis or those who do not have cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better management strategies for older adults with both rheumatoid arthritis and cancer.
How similar studies have performed: While some studies have explored the relationship between RA and cancer survival, this research aims to provide new insights based on contemporary treatment approaches, making it a novel investigation.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Singh, Namrata — University of Washington
- Study coordinator: Singh, Namrata
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.